Cargando…

Barriers to uptake of antenatal maternal screening tests in Senegal

BACKGROUND: Evidence exists that selective antenatal maternal screening tests contribute to the reduction of maternal morbidity and mortality. However, data are lacking on coverage with the complete set of recommended tests. The study aimed to identify barriers to uptake of the complete set of tests...

Descripción completa

Detalles Bibliográficos
Autores principales: Koster, Winny, Ondoa, Pascale, Sarr, Aïcha Marceline, Sow, Ahmad Iyane, Schultsz, Constance, Sakande, Jean, Diallo, Souleymane, Pool, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5757953/
https://www.ncbi.nlm.nih.gov/pubmed/29349190
http://dx.doi.org/10.1016/j.ssmph.2016.10.003
_version_ 1783290918468583424
author Koster, Winny
Ondoa, Pascale
Sarr, Aïcha Marceline
Sow, Ahmad Iyane
Schultsz, Constance
Sakande, Jean
Diallo, Souleymane
Pool, Robert
author_facet Koster, Winny
Ondoa, Pascale
Sarr, Aïcha Marceline
Sow, Ahmad Iyane
Schultsz, Constance
Sakande, Jean
Diallo, Souleymane
Pool, Robert
author_sort Koster, Winny
collection PubMed
description BACKGROUND: Evidence exists that selective antenatal maternal screening tests contribute to the reduction of maternal morbidity and mortality. However, data are lacking on coverage with the complete set of recommended tests. The study aimed to identify barriers to uptake of the complete set of tests recommended by the Ministry of Health in Senegal. METHODS: Data were collected in communities, antenatal care (ANC) clinics and the laboratories of 11 public health care facilities across Senegal. Mixed-methods included ethnography (observations and informal conversations), in-depth interviews and workshops at the health facilities; structured interviews with 283 women receiving antenatal tests (“women in the lab”); in-depth interviews with 81 women in communities who were pregnant or had recently delivered (“community women”). RESULTS: Only 13% of community women and 22% of women in the lab had received the complete set of tests. For various social, financial and antenatal care-related reasons 38% of community women who visited antenatal care facilities did not access a laboratory. The lowest test uptake was in women receiving antenatal care at health posts. Barriers at the laboratory level were the cost of the test, stock-outs of reagents, and broken equipment. Midwives were the main gatekeepers of the laboratory, not requesting (all) tests because of assumptions about women's financial problems and reliance on clinical symptoms. CONCLUSION: In Senegal, recommended antenatal maternal screening tests are substantially underutilized. Efforts to increase test uptake should include accessible testing guidelines, reducing the cost of tests, raising awareness about the reasons for tests, and making the complete test set in point-of-care format accessible in peripheral health posts. National and international antenatal care policies and programs should facilitate access to maternal screening tests as a contribution to reducing maternal and infant morbidity and mortality.
format Online
Article
Text
id pubmed-5757953
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-57579532018-01-18 Barriers to uptake of antenatal maternal screening tests in Senegal Koster, Winny Ondoa, Pascale Sarr, Aïcha Marceline Sow, Ahmad Iyane Schultsz, Constance Sakande, Jean Diallo, Souleymane Pool, Robert SSM Popul Health Article BACKGROUND: Evidence exists that selective antenatal maternal screening tests contribute to the reduction of maternal morbidity and mortality. However, data are lacking on coverage with the complete set of recommended tests. The study aimed to identify barriers to uptake of the complete set of tests recommended by the Ministry of Health in Senegal. METHODS: Data were collected in communities, antenatal care (ANC) clinics and the laboratories of 11 public health care facilities across Senegal. Mixed-methods included ethnography (observations and informal conversations), in-depth interviews and workshops at the health facilities; structured interviews with 283 women receiving antenatal tests (“women in the lab”); in-depth interviews with 81 women in communities who were pregnant or had recently delivered (“community women”). RESULTS: Only 13% of community women and 22% of women in the lab had received the complete set of tests. For various social, financial and antenatal care-related reasons 38% of community women who visited antenatal care facilities did not access a laboratory. The lowest test uptake was in women receiving antenatal care at health posts. Barriers at the laboratory level were the cost of the test, stock-outs of reagents, and broken equipment. Midwives were the main gatekeepers of the laboratory, not requesting (all) tests because of assumptions about women's financial problems and reliance on clinical symptoms. CONCLUSION: In Senegal, recommended antenatal maternal screening tests are substantially underutilized. Efforts to increase test uptake should include accessible testing guidelines, reducing the cost of tests, raising awareness about the reasons for tests, and making the complete test set in point-of-care format accessible in peripheral health posts. National and international antenatal care policies and programs should facilitate access to maternal screening tests as a contribution to reducing maternal and infant morbidity and mortality. Elsevier 2016-10-13 /pmc/articles/PMC5757953/ /pubmed/29349190 http://dx.doi.org/10.1016/j.ssmph.2016.10.003 Text en © 2016 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Koster, Winny
Ondoa, Pascale
Sarr, Aïcha Marceline
Sow, Ahmad Iyane
Schultsz, Constance
Sakande, Jean
Diallo, Souleymane
Pool, Robert
Barriers to uptake of antenatal maternal screening tests in Senegal
title Barriers to uptake of antenatal maternal screening tests in Senegal
title_full Barriers to uptake of antenatal maternal screening tests in Senegal
title_fullStr Barriers to uptake of antenatal maternal screening tests in Senegal
title_full_unstemmed Barriers to uptake of antenatal maternal screening tests in Senegal
title_short Barriers to uptake of antenatal maternal screening tests in Senegal
title_sort barriers to uptake of antenatal maternal screening tests in senegal
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5757953/
https://www.ncbi.nlm.nih.gov/pubmed/29349190
http://dx.doi.org/10.1016/j.ssmph.2016.10.003
work_keys_str_mv AT kosterwinny barrierstouptakeofantenatalmaternalscreeningtestsinsenegal
AT ondoapascale barrierstouptakeofantenatalmaternalscreeningtestsinsenegal
AT sarraichamarceline barrierstouptakeofantenatalmaternalscreeningtestsinsenegal
AT sowahmadiyane barrierstouptakeofantenatalmaternalscreeningtestsinsenegal
AT schultszconstance barrierstouptakeofantenatalmaternalscreeningtestsinsenegal
AT sakandejean barrierstouptakeofantenatalmaternalscreeningtestsinsenegal
AT diallosouleymane barrierstouptakeofantenatalmaternalscreeningtestsinsenegal
AT poolrobert barrierstouptakeofantenatalmaternalscreeningtestsinsenegal